Biostatistics Core
Biostatistics Core
批准号:
8588552
负责人:
Matthew D Ringel
金额:
$14.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-25 至 2018-07-31
关键词:
AddressAdherenceBiologicalBiological MarkersBiometryBiostatistics CoreCancer CenterClinicalClinical ResearchClinical TrialsClinical Trials DesignCollaborationsCommunicationComplexConduct Clinical TrialsDataData AnalysesData DisplayData QualityDevelopmentDrug FormulationsEnsureExperimental DesignsInferiorInstructionInvestigationLaboratoriesLeadLiteratureMaintenanceMalignant neoplasm of thyroidMentorsMethodologyMethodsObservational StudyOhioOnline SystemsPilot ProjectsPlayProceduresProspective StudiesQuality ControlRandomizedReportingResearchResearch InfrastructureResearch MethodologyResearch PersonnelResourcesRetrospective StudiesRoleSample SizeSecurityServicesStagingStatistical MethodsStatistical ModelsStatistical StudyStatistical sensitivityTNFRSF5 geneTestingThinkingTrainingUniversitiesValidationVisualbasebiobankdata integrationdata integritydata managementdesignexpectationexperiencemeetingspredictive modelingquality assurancerepositoryresearch studysuccess
中文摘要
生物统计核心的主要目标将是为项目调查员提供集中的资源
生物统计学方面的专业知识。统计问题将在所有级别的调查中得到解决:从设计
临床试验和实验室实验,到数据质量的维护;以及从基于
正式的假设检验,通过彻底的数据探索发现重要线索。为了支持这一点
目标,核心的具体目标包括:
1.设计:与项目研究人员合作设计临床研究和实验室
实验,明确假设和假设检验策略的表述,以及
预测模型的开发和验证。
分析:提供支持:对临床和实验数据进行正式假设检验,以确保
强有力的结论;前瞻性和回溯性的统计建模和敏感性分析
研究.预测模型的发现、训练和验证的综合分析.探索性
导致进一步研究和实验的分析;以及数据的可视化显示,以澄清
结论和发现线索。
监督和基础设施:为临床试验提供监督,包括设计遵守和
中期分析、基于网络的随机化和数据协调服务。
数据质量保证:管理数据并与综合临床病理学协调服务
和生物仓库核心,以确保所有临床研究人员的高质量、安全性和可访问性
和实验数据。
方法研究:研究直接处理困难数据或设计的新方法
有问题。
试点项目:为试点项目提供设计和数据分析支持。
相关性(请参阅说明):
生物统计核心将为实验和研究的规划和设计提供关键支持,
数据的统计分析和显示,以及数据管理和完整性。此支持旨在
确保研究得出可靠的结论,有效利用资源,并进行探索性分析
发现重要线索。
英文摘要
The principal objective of the Biostatistics Core will be to provide project investigators a centralized resource
for biostatistics expertise. Statistical issues will be addressed at all levels of investigation: from the design of
clinical trials and laboratory experiments, to the maintenance of data quality; and from conclusions based on
formal hypothesis testing, to important leads discovered by thorough data exploration. In support of this
objective, the specific aims of the Core include:
1. Design: collaborate with project investigators in the design of clinical studies and laboratory
experiments, formulation of unambiguous hypotheses and hypothesis testing strategies, and
development and validation of predictive models.
Analysis: provide support with: formal hypothesis tests in clinical and experimental data that ensure
strong conclusions; statistical modeling and sensitivity analyses of prospective and retrospective
studies; integrated analyses for discovery, training, and validation of predictive models; exploratory
analyses that lead to further studies and experiments; and visual displays of data that clarify
conclusions and uncover leads.
Oversight and Infrastructure: provide oversight for the clinical trials, including design adherence and
interim analyses, web based randomization, and data coordination services.
Data Quality Assurance: manage data and coordinate services with the Integrated Clinicopathology
and Biorepository Core to ensure high quality, security and investigator accessibility for all clinical
and experimental data.
Methods Research: Investigate new methodologies to directly address difficult data or design
problems.
Pilot projects: provide design and data analytic support for pilot projects.
RELEVANCE (See instructions):
The Biostatistics Core will provide critical support for planning and design of experiments and studies,
statistical analyses and display of data, and data management and integrity. This support is designed to
ensure that studies yield reliable conclusions, resources are efficiently used, and exploratory analyses
uncover important leads.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RCAN 1.4 metastasis suppressor in thyroid cancer
-
批准号:9973560
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2020
-
负责人:Matthew D Ringel
-
依托单位:
RCAN 1.4 metastasis suppressor in thyroid cancer
-
批准号:10604328
-
项目类别:
-
资助金额:$44.53万
-
财政年份:2020
-
负责人:Matthew D Ringel
-
依托单位:
RCAN 1.4 metastasis suppressor in thyroid cancer
-
批准号:10400004
-
项目类别:
-
资助金额:$44.34万
-
财政年份:2020
-
负责人:Matthew D Ringel
-
依托单位:
Role of p21-activated kinases in thyroid cancer
-
批准号:10377551
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2018
-
负责人:Matthew D Ringel
-
依托单位:
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
-
批准号:10414809
-
项目类别:
-
资助金额:$462.14万
-
财政年份:2018
-
负责人:Matthew D Ringel
-
依托单位:
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
-
批准号:8741949
-
项目类别:
-
资助金额:$216.2万
-
财政年份:2013
-
负责人:Matthew D Ringel
-
依托单位:
Developing Combination Therapies for Medullary Thyroid Cancer
-
批准号:8588547
-
项目类别:
-
资助金额:$28.39万
-
财政年份:2013
-
负责人:Matthew D Ringel
-
依托单位:
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
-
批准号:8548721
-
项目类别:
-
资助金额:$215.05万
-
财政年份:2013
-
负责人:Matthew D Ringel
-
依托单位:
Integrated Clinicopathology and Biorespository Core
-
批准号:8588551
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2013
-
负责人:Matthew D Ringel
-
依托单位:
Administrative Core
-
批准号:8588554
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2013
-
负责人:Matthew D Ringel
-
依托单位:
RCAN1 in Thyroid Cancer Progression
-
批准号:8235810
-
项目类别:
-
资助金额:$33.59万
-
财政年份:2011
-
负责人:Matthew D Ringel
-
依托单位:
RCAN1 in Thyroid Cancer Progression
-
批准号:8403904
-
项目类别:
-
资助金额:$31.35万
-
财政年份:2011
-
负责人:Matthew D Ringel
-
依托单位:
RCAN1 in Thyroid Cancer Progression
-
批准号:8784195
-
项目类别:
-
资助金额:$33.07万
-
财政年份:2011
-
负责人:Matthew D Ringel
-
依托单位:
RCAN1 in Thyroid Cancer Progression
-
批准号:8108692
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2011
-
负责人:Matthew D Ringel
-
依托单位:
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
-
批准号:8145140
-
项目类别:
-
资助金额:$13.14万
-
财政年份:2008
-
负责人:Matthew D Ringel
-
依托单位:
Administrative Core
-
批准号:8506025
-
项目类别:
-
资助金额:$11.37万
-
财政年份:2008
-
负责人:Matthew D Ringel
-
依托单位:
p21 Activated Kinase in Thyroid Cancer
-
批准号:9041531
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2008
-
负责人:Matthew D Ringel
-
依托单位:
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
-
批准号:8064255
-
项目类别:
-
资助金额:$224.77万
-
财政年份:2008
-
负责人:Matthew D Ringel
-
依托单位:
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
-
批准号:9246457
-
项目类别:
-
资助金额:$229.72万
-
财政年份:2008
-
负责人:Matthew D Ringel
-
依托单位:
Genetic and Signaling Pathways in Epithelial Thyroid Cancer
-
批准号:9041526
-
项目类别:
-
资助金额:$228.92万
-
财政年份:2008
-
负责人:Matthew D Ringel
-
依托单位:
海外基金